观察玉屏风颗粒联合咪唑斯汀治疗慢性湿疹的临床疗效  

Clinical effect of Yupingfeng granule combined with mizolastine in the treatment of chronic eczema

作　　者：邵丰德[1] 曲昭虎 SHAO Feng-de;QU Zhao-hu(Department of Pharmacy,Dalian Dermatology Hospital,Dalian 116000,China)

机构地区：[1]大连市皮肤病医院,116000 [2]大连市卫生健康事业发展中心,116000

出　　处：《中国实用医药》2021年第10期155-157,共3页China Practical Medicine

摘　　要：目的分析观察玉屏风颗粒联合咪唑斯汀治疗慢性湿疹的临床疗效。方法选择106例慢性湿疹患者作为研究对象,按照入院先后顺序分为对照组和观察组,每组53例。对照组患者采用咪唑斯汀进行治疗,观察组患者采用咪唑斯汀联合玉屏风颗粒进行治疗。比较两组患者治疗后临床疗效及不良反应发情况。结果观察组患者总有效率94.34%(50/53)高于对照组的73.58%(39/53),差异有统计学意义(P<0.05)。观察组患者不良反应发生率5.66%(3/53)低于对照组的18.87%(10/53),差异有统计学意义(P<0.05)。结论临床上在针对慢性湿疹患者进行治疗的过程中,采用玉屏风颗粒联合咪唑斯汀药物进行治疗具有更好的效果,能够实现患者整体治疗有效率的提升,同时,相关治疗方法具有更高的安全性。Objective To analyze the clinical efficacy of Yupingfeng granule combined with mizolastine in the treatment of chronic eczema. Methods A total of 106 patients with chronic eczema as study subjects were divided into control group and observation group according to admission order, with 53 cases in each group. The control group was treated with mizolastine, and the observation group was treated with Yupingfeng granule combined with mizolastine. The clinical efficacy and occurrence of adverse reactions after treatment were compared between the two groups. Results The total effective rate 94.34%(50/53) of the observation group was significantly higher than 73.58%(39/53) of the control group, and the difference was statistically significant(P<0.05). The incidence of adverse reactions 5.66%(3/53) of the observation group was lower than 18.87%(10/53) of the control group, and the difference was statistically significant(P<0.05). Conclusion Yupingfeng granule combined with mizolastine has better effect on patients with chronic eczema, and it can improve the overall effect of patients.

关 键 词：玉屏风颗粒 咪唑斯汀 治疗 慢性湿疹 临床疗效 

分 类 号：R758.23[医药卫生—皮肤病学与性病学]